Clear aligners
DeviceCustom thermoplastic aligners worn 20-22 hours daily with sequential staged movements for space closure.
NCT Number: NCT07778095
This study is a prospective 2x2 factorial randomized clinical trial designed to evaluate and compare the closure efficiency and post-treatment stability of diastema associated with generalized interdental spacing (width >= 3 mm) treated with clear aligners versus fixed orthodontic appliances, with and without adjunctive laser frenectomy. Participants are randomized into four treatment arms to assess the main effects and interaction effects of appliance modality and laser frenectomy. Stability and relapse rates are systematically tracked across active treatment, a 6-month retention period, and post-retention follow-up intervals at 6 and 8 months.
Trial opening soon.
Get Notified18 year–35 year
All sexes
Interventional
Not applicable
Diastema associated with generalized interdental spacing (>= 3 mm) represents a challenging orthodontic condition with a heightened risk of post-treatment relapse. While fixed appliances provide reliable three-dimensional tooth movement control, clear aligners offer improved esthetics and patient comfort. Additionally, the role and timing of adjunctive laser frenectomy in stabilizing space closure remain controversial in generalized spacing cases.
This prospective 2x2 factorial randomized clinical trial is conducted at the Orthodontic Clinics, Faculty of Dentistry, Sana'a University, Yemen. A total of 48 eligible participants are randomly allocated into four equal groups (n=12 per group):
Treatment Protocols:
Retention and Evaluation:
All participants follow a standardized retention protocol for 6 months post-treatment. Clinical, digital (Zahndent intraoral scanner), and radiographic (digital periapical sensor) assessments are conducted at five measurement time points:
The primary outcome is the amount of diastema relapse (mm). Secondary outcomes include total space closure, root parallelism, and relapse rates.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Custom thermoplastic aligners worn 20-22 hours daily with sequential staged movements for space closure.
Metal brackets with MBT 0.022-inch slot prescription and sequential archwires for controlled space closure.
Surgical ablation and tissue excision of the labial frenum performed using a soft-tissue diode laser.
Time frame: Baseline (0 months), 18 months, 24 months, 30 months, and 32 months
Linear measurement (in millimeters) of maxillary median diastema relapse evaluated on digital 3D models (obtained via intraoral scanner) to measure space reopening post-treatment.
Time frame: Up to 18 months
Total duration (months) to achieve complete space closure and the rate of space closure per month (mm/month) measured from digital 3D models.
Time frame: Baseline and 18 months
Assessment of central incisor root parallelism and root position (bodily movement vs tipping) measured in degrees on digital periapical radiographs.
Time frame: Baseline, 18 months, and 32 months
Linear measurement of labial frenum attachment level (in millimeters relative to the mucogingival junction).
Contact information is provided by the study sponsor or research team.
Sana'a University
Other
Closure and Stability of Diastema Associated With Generalized Interdental Spacing Using Clear Aligners Versus Fixed Appliances With Adjunctive Frenectomy: A 2x2 Factorial RCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04515069
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Cairo, Egypt
View Trial DetailsNCT02893735
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07753070
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alexandria, Egypt
View Trial DetailsNCT07718191
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
View Trial Details